Stem cells: Prospects for functional repair of brain damage

Transplantation Proceedings

Volumn 35, Issue 3, 2003, Pages 1250-1255

  Hodges, H ^a   Watts, H ^b   Reuter, I ^b  

^a RENEURON LTD   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN;

BRAIN INJURY; CARCINOGENESIS; CELL ACTIVITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL MIGRATION; CELL REGENERATION; CONFERENCE PAPER; DEVELOPMENTAL STAGE; DONOR; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KARYOTYPE; MEDICAL ETHICS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; STEM CELL TRANSPLANTATION; TREATMENT FAILURE; TREATMENT OUTCOME; VIRUS INFECTION;

EID: 0038707387     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00207-0     Document Type: Conference Paper

References (31)

1. Björklund A., Lindvall O. Nat Neurosci. 3:2000;537.
2. Hodges H. Ginsberg M.D., Bogousslavsky J. Cerebrovascular Disease, Vol. 1 Pathophysiology, Diagnosis and Management . 1998;644 Blackwell Scientific Publications Inc, Boston, Mass.
3. Sinden J.D., Stroemer P., Grigoryan G., et al. Chadwick D.J., Goode J.A. Neural Transplantation in Neurodegenerative Disease Current Status and New Directions. Novartis Foundation Symposium 231 . 2000;270 John Wiley & Sons Ltd, Chichester, UK.
4. Lindvall O. Chadwick D.J., Goode J.A. Neural Transplantation in Neurodegenerative Disease Current Status and New Directions. Novartis Foundation Symposium 231 . 2000;110 John Wiley & Sons Ltd, Chichester, UK.
5. Freed C.R., Greene P.E., Breeze R.E., et al. N Engl J Med. 344:2001;701.
6. Polkinghorne J., et al. Review of the Guidance on the Research Use of Fetuses and Fetal Material. 1989;HMSO, London. p 762.
7. Flax J.D., Aurora S., Yang C., et al. Nat Biotechnol. 16:1998;1033.
8. Fricker R.A., Carpenter M.K., Winkler C., et al. J Neurosci. 19:1999;5990.
9. Modo M., Stroemer R.P., Tang E., et al. Stroke. 33:2002;2270.
10. Mujtaba T., Mayer-Proschel M., Rao M.S. Dev Biol. 200:1998;1.
11. Björnson C.R., Reynolds B.A., Magli M.C., et al. Science. 283:1999;534.
12. Lui J., Solway K., Messing R.O., et al. J Neurosci. 18:1998;7768.
13. Borlongan C.V., Tajima Y., Trojanowski J.Q., et al. Exp Neurol. 149:1998;310.
14. Kondziolka D., Wechsler L., Goldstein S., et al. Neurology. 55:2000;565.
15. Gray J.A., Hodges H., Sinden J.D. Phil Trans R Soc Lond B. 354:1999;1407.
16. Gray J.A., Grigoryan G., Virley D., et al. Cell Transplant. 9:2000;153.
17. Hodges H., Sowinski P., Virley D., et al. Chadwick D.J., Goode J.A. Neural Transplantation in Neurodegenerative Disease Current Status and New Directions. Novartis Foundation Symposium 231 . 2000;53 John Wiley, Chichester, UK.
18. Sinden J.D., Rashid-Doubell F., Kershaw T., et al. Neuroscience. 81:1997;599.
19. Virley D., Ridley R.M., Sinden J.D., et al. Brain. 122:1999;2321.
20. Veizovic T., Beech J.S., Stroemer R.P., et al. Stroke. 32:2001;1012.
21. Meldrum B.S., Chapman A.G., Tang E., et al. Acta Neurol Scand. 102:(suppl 175):2000;45.
22. Rezvani M., Birds D.A., Hodges H., et al. Radiat Res. 156:2001;408.
23. Reuter I., Chaudhuri K.R., Hodges H. Neurology. 56:(suppl 3):2001;A385.
24. Price J., Uwangho D., Peters S., et al. Chadwick D.J., Goode J.A. Neural Transplantation in Neurodegenerative Disease Current Status and New Directions. Novartis Foundation Symposium 231 . 2000;148 John Wiley & Sons Ltd, Chichester.
25. Björklund L.M., Sanchez-Pernaute R., Chung S., et al. Proc Natl Acad Sci U S A. 19:2002;2344.
26. Jat P.S., Noble M.D., Ataliotis P., et al. Proc Natl Acad Sci U S A. 88:1991;5096.
27. Paradis K., Langford G., Long Z., et al. Science. 285:1999;1236.
28. Van Der Laan L.J.W., Lockey C., Griffeth G.C., et al. Nature. 407:2000;90.
29. Rehen S.K., McConnell M.J., Kaushal D., et al. Proc Natl Acad Sci U S A. 98:2001;13361.
30. Grigoryan G.A., Gray J.A., Rashid T., et al. Rest Neurol Neurosci. 17:2000;183.
31. Hodges H., Veizovic T., Bray N., et al. Neuroscience. 101:2000;945.